U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07500168) titled 'Fighting the Fear of Cancer Recurrence in Cancer Survivors: A Pilot Study on the Effectiveness of Metacognitive Therapy' on March 24.
Brief Summary: This study aims to evaluate the effectiveness of metacognitive therapy (MCT) in reducing fear of cancer recurrence (FCR) among cancer survivors.
With advances in cancer treatment, more patients are surviving cancer. However, many survivors continue to experience fear of cancer recurrence, which can affect their emotional well-being, quality of life, and ability to return to normal daily activities.
In this study, participants will receive a structured psychological intervention adapt...